EUCTR2016-003669-24-IT进行中（未招募）1 期
Amyloid PET imaging study for the diagnosis of Alzheimer's disease in the preclinical/predementia phase - Non Disponibile
OSPEDALE SAN RAFFAELE0 个研究点目标入组 180 人开始时间: 2021年10月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •diagnosis of memory complaint, mild cognitive impairment or Alzheimer disease; age > 18 years old
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 80
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •presence of other neurological and clinical condition responsible of cognitive disorders; liver and kidney failure; pregnancy and breastfeeding; fertile women do not using contraceptive drugs; hypersensitivity to active principle and excipients (ascorbic acid; anidre ethanol; macrogol 400; ascorbic sodium; water for injections)
研究者
相似试验
已完成
不适用
Studies on the amyloid PET imaging in patients with dementiapatients with dementiaJPRN-UMIN000010767Mie University Graduate School of Medicine30
已完成
不适用
Amyloid imaging study using positron emission tomography with [F-18]FACT for dementiaDementiaJPRN-UMIN000001420ational Institute of Radiological Sciences60
已完成
不适用
Amyloid PET imaging study for dimenting disordersdementing disorderJPRN-UMIN000028758Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama20
已完成
不适用
Evaluation of Amyloid Imaging in People with Metabolic Disorder Identified by Brain FDG-PET as Part of a Complete Medical CheckupAlzheimer diseaseJPRN-UMIN000011612School of medicine, Keio University100
已完成
不适用
PET Imaging of Brain Amyloid Using 11C-PIB in Neurological DiseasesAlzheimer's disease Neurodegenerative diseasesJPRN-UMIN000004195Human Brain Research Center, Kyoto University Graduate School of Medicine50